Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.

Song EJ, Ehst B, Glick B, Lewitt GM, Rich P, Ezra N, Bagel J, Anschutz T, Bialik B, Duan C, Ashley D, Patel M, St John G, Setty AR, Ackerman L

Open source

DOI: 10.1007/s13555-025-01544-6
Published: 2026 Jan
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01544-6,
  title = {Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.},
  author = {Song EJ and Ehst B and Glick B and Lewitt GM and Rich P and Ezra N and Bagel J and Anschutz T and Bialik B and Duan C and Ashley D and Patel M and St John G and Setty AR and Ackerman L},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-025-01544-6},
  url = {https://doi.org/10.1007/s13555-025-01544-6}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.
AU  - Song EJ
AU  - Ehst B
AU  - Glick B
AU  - Lewitt GM
AU  - Rich P
AU  - Ezra N
AU  - Bagel J
AU  - Anschutz T
AU  - Bialik B
AU  - Duan C
AU  - Ashley D
AU  - Patel M
AU  - St John G
AU  - Setty AR
AU  - Ackerman L
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-025-01544-6
UR  - https://doi.org/10.1007/s13555-025-01544-6
ER  -

APA

EJ, S., B, E., B, G., GM, L., P, R., N, E., J, B., T, A., B, B., C, D., D, A., M, P., G, S. J., AR, S., & L, A. (2026). Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.. Dermatology and therapy. https://doi.org/10.1007/s13555-025-01544-6

Source records

pubmed · retrieved 2026-09-26T00:33:34.481Z
europe-pmc · retrieved 2026-09-26T00:33:34.512Z
doaj · retrieved 2026-09-26T00:33:34.522Z